ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,718.57
      0.28%
      US Tech 100
      19,312.80
      0.08%
      Dow Jones
      42,124.65
      0.15%
      Brent Oil
      74.14
      0.55%
      Bitcoin
      63,155.34
      -0.27%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Virios Therapeutics Inc (VIRI) Quote

      Virios Therapeutics Inc

      Virios Therapeutics Inc (VIRI)

      Viridien
      0.1942
      -0.0051
      (-2.56%)
      Closed September 24 4:00PM
      Delayed by 15 minutes
      0.1942
      0.00
      (0.00%)
      After Hours: 5:04PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.1942
      Bid
      0.185
      Ask
      0.2049
      Volume
      588,330
      0.1851 Day's Range 0.219
      0.1557 52 Week Range 1.04
      Market Cap
      5.391M
      Previous Close
      0.1993
      Open
      0.195
      Last Trade
      1
      @
      0.195
      Last Trade Time
      Financial Volume
      $ 114,851
      VWAP
      0.195216
      Average Volume (3m)
      1,018,448
      Shares Outstanding
      27,757,937
      Dividend Yield
      -
      PE Ratio
      -1.00
      Earnings Per Share (EPS)
      -0.19
      Revenue
      -
      Net Profit
      -5.3M

      About Virios Therapeutics Inc

      Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people wh... Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.virios.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Virios Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRI. The last closing price for Virios Therapeutics was $0.20. Over the last year, Virios Therapeutics shares have traded in a share price range of $ 0.1557 to $ 1.04.

      Virios Therapeutics currently has 27,757,937 shares outstanding. The market capitalization of Virios Therapeutics is $5.53 million. Virios Therapeutics has a price to earnings ratio (PE ratio) of -1.00.

      Ask ADVFN Intelligence (AI)

      VIRI Latest News

      More News

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 09 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 08 2024
      Edgar (US Regulatory)

      Virios Therapeutics Announces Second Quarter 2024 Financial Results

      - Bateman Horne Center completed enrollment in its groundbreaking investigator-initiated Long-COVID phase 2a study featuring valacyclovir and celecoxib (IMC-2) - - Top-line results from the...

      August 08 2024
      GlobeNewswire Inc.

      Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

      ATLANTA, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to...

      August 01 2024
      GlobeNewswire Inc.

      Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center

      - Virios projects releasing top line results from this groundbreaking Proof of Concept study in October 2024 - - Published data indicates increased Epstein-Barr herpes virus in Long-COVID...

      July 23 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      June 20 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 12 2024
      Edgar (US Regulatory)

      Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

      ATLANTA, May 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel...

      May 22 2024
      GlobeNewswire Inc.

      Form 424B4 - Prospectus [Rule 424(b)(4)]

      May 20 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 20 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.00422.210526315790.190.22820.1873783170.2007756CS
      4-0.0108-5.268292682930.2050.240.174461770.19561637CS
      12-0.0148-7.081339712920.2090.33290.16210184480.23246719CS
      26-0.2558-56.84444444440.450.58210.155710385980.242679CS
      52-0.7337-79.07102058410.92791.040.15577060660.34456949CS
      156-5.0058-96.26538461545.29.11090.15576440340.7539702CS
      260-13.5658-98.588662790713.7614.390.15575533241.25937724CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KAVLKaival Brands Innovations Group Inc
      $ 1.33
      (129.71%)
      		182.46M
      LASELaser Photonics Corporation
      $ 18.8671
      (81.24%)
      		13.54M
      TGLTreasure Global Inc
      $ 1.18
      (73.45%)
      		139.95M
      NVVENuvve Holding Corporation
      $ 6.68
      (70.41%)
      		31.34M
      UXINUxin Ltd
      $ 2.42
      (52.68%)
      		18.24M
      ELABElevai Labs Inc
      $ 0.10545
      (-62.34%)
      		23.66M
      ADTXAditxt Inc
      $ 0.262
      (-31.52%)
      		3.17M
      FRGTFreight Technologies Inc
      $ 0.081
      (-28.82%)
      		26.36M
      ANEBAnebulo Pharmaceuticals Inc
      $ 2.23
      (-27.60%)
      		113.78k
      STSSSharps Technology Inc
      $ 0.1722
      (-27.06%)
      		2.28M
      XPONExpion360 Inc
      $ 0.1144
      (34.91%)
      		432.21M
      NVDANVIDIA Corporation
      $ 116.26
      (0.22%)
      		206.23M
      INTCIntel Corporation
      $ 22.56
      (3.30%)
      		184.44M
      KAVLKaival Brands Innovations Group Inc
      $ 1.33
      (129.71%)
      		182.46M
      TGLTreasure Global Inc
      $ 1.18
      (73.45%)
      		139.95M

      VIRI Discussion

      View Posts
      LowFloatLopes LowFloatLopes 7 days ago
      FYI it’s still summer lol 4 more days …
      👍️0
      maq1214 maq1214 2 weeks ago
      Just one month away from a Reverse split, Thank you Mr Greg Duncan you are a mastermind in this. What happened to the destined partnership for Phase 3 Fibromyalgia, even given a commencing date of summer 2024- I guess it all lies, no one should trust this moron
      👍️0
      maq1214 maq1214 2 months ago
      Why greg Duncan stretching a lot of news such as partnership of fibromyalgia and Long covid data? feels like reverse split is imminent
      👍️0
      georgie18 georgie18 2 months ago
      VIRI...1947...Back in here on the Double Bottom...🥳
      👍️0
      Gold prospector Gold prospector 2 months ago
      Exactly, my biggest fear is no volume and the shorts push it down
      👍️0
      DavidLeeRoth DavidLeeRoth 2 months ago
      I hope you’re right bud! We’ll all know before the middle of October. VIRI LONG💰
      👍️0
      Gold prospector Gold prospector 2 months ago
      No RS
      👍️0
      maq1214 maq1214 2 months ago
      Happy Monday to all. What's happening with VIRI? feels like RS is happening sooner than later
      👍️0
      maq1214 maq1214 2 months ago
      I hope so. been holding 150 thousand shares, total gamble
      👍️ 1
      DavidLeeRoth DavidLeeRoth 2 months ago
      I believe we move above $1/share without a RS. VIRI LONG💰
      👍️0
      maq1214 maq1214 2 months ago
      News expected October. Compliance deadline is 28th October. Do you reckon we avoid a reverse split ?
      👍️0
      DavidLeeRoth DavidLeeRoth 2 months ago
      VIRI NEWS!!

      https://ir.virios.com/news/press-releases/detail/120/virios-therapeutics-announces-completion-of-enrollment-in
      👍️0
      DavidLeeRoth DavidLeeRoth 2 months ago
      Nice $37,000 BID for a Friday morning😉 VIRI LONG💰
      👍️0
      DavidLeeRoth DavidLeeRoth 2 months ago
      What?🤣😆 VIRI LONG💰💰
      👍️0
      maq1214 maq1214 2 months ago
      very disappointed atm :(
      👍️0
      gail gail 2 months ago
      if it keeps dipping, i may get back in.
      👍️ 1
      DavidLeeRoth DavidLeeRoth 2 months ago
      Multiple dollars could come quickly here folks!! VIRI LONG💰
      👍️ 1
      DavidLeeRoth DavidLeeRoth 2 months ago
      I’m sure you will be fine😎 They drop some IMC-1 phase 3 partnership news, and we’re off to the races!!💰
      👍️ 1
      gail gail 2 months ago
      looks like i should have waited, lol
      👍️0
      gail gail 2 months ago
      hi cj! i just grabbed some pre market.
      👍️ 1
      DavidLeeRoth DavidLeeRoth 2 months ago
      Gotta be!! Over 7 million traded now, and hit .39 earlier.😎
      👍️ 1
      Carjockey2 Carjockey2 2 months ago
      News coming????
      👍️ 1
      DavidLeeRoth DavidLeeRoth 2 months ago
      6 million shares already traded premarket!! Let’s go VIRI😎💰
      👍️ 1 💯 1
      Golden Cross Golden Cross 2 months ago
      $trong AH's 💲💲💲
      👍️ 1
      DavidLeeRoth DavidLeeRoth 2 months ago
      VIRI up over 22%. Partnership news could be dropping folks!!
      👍️0
      DavidLeeRoth DavidLeeRoth 2 months ago
      Up 10% with some nice ASK slapping!! News leak??
      👍️0
      maq1214 maq1214 3 months ago
      if this holds above the resistance, uptrend incoming !
      👍️0
      maq1214 maq1214 3 months ago
      thought we were expecting results by the summer or August. I guess there are still enrolling, anyone has any information about this?

      Dr. Lucinda Bateman is the Principal Investigator for a phase 2 randomized placebo-controlled #clinicaltrial of valacyclovir plus celecoxib for the treatment of #LongCOVID.
      🧪This trial needs to enroll an additional 10 women with #LongCOVID to participate. Link in comments. pic.twitter.com/AyG850tCxR— Bateman Horne Center (@BatemanHorne) July 3, 2024
      👍️0
      Klinsmann Klinsmann 3 months ago
      Has been nice 50% gains…
      👍️0
      skydog526 skydog526 3 months ago
      This will go back into the toilet, then RS. The promo pump fest on stocktwits is over. No worries I've got plenty of shares of this garbage like you all.
      👍️0
      DavidLeeRoth DavidLeeRoth 3 months ago
      I’m pretty sure we can do much better than $1😎 VIRI LONG💰

      👍️0
      JUST 10-11-12 JUST 10-11-12 3 months ago
      great!
      👍️ 1
      DavidLeeRoth DavidLeeRoth 3 months ago
      TEAM VIRI getting noticed😎💰

      Virios is pleased that Maxim Group has initiated research coverage with its first research report by analyst Jason McCarthy. Note: Analyst research is conducted independently of the company, and Virios does not endorse or adopt the views expressed in any analyst research report.— Virios Therapeutics (@ViriosBiotech) June 20, 2024
      👍️ 1
      DavidLeeRoth DavidLeeRoth 3 months ago
      Hi everyone, I like what I heard today, as IMC-2 is being well tolerated by patients, and IMC-1 sounds like it may be attractive for a partnership going into phase 3, and it sounds like we are definitely going to get to $1 without a R/S. This is all just IMO of course, but I’m adding more😎
      👍️ 1
      Smarkel Smarkel 3 months ago
      What they said?
      👍️0
      DavidLeeRoth DavidLeeRoth 3 months ago
      Meeting just ended, and it sure does sound like VIRIOS will be trading above $1 without a reverse split before October 28th😎 VIRI LONG💰
      👍️0
      DavidLeeRoth DavidLeeRoth 3 months ago
      Don’t forget the meeting tomorrow at 1100 folks!! VIRI💰

      https://ir.virios.com/
      👍️0
      Klinsmann Klinsmann 3 months ago
      Toute est possible…
      👍️0
      maq1214 maq1214 3 months ago
      Can this regain compliance organically before the deadline of October ?
      👍️0
      DavidLeeRoth DavidLeeRoth 3 months ago
      8-K out. VIRI💰

      Nasdaq extension until October 28, 2024.

      https://www.sec.gov/ix?doc=/Archives/edgar/data/0001818844/000155837024009066/viri-20240611x8k.htm
      👍️0
      glenn1919 glenn1919 4 months ago
      VIRI......................https://stockcharts.com/h-sc/ui?s=VIRI&p=W&b=5&g=0&id=p86431144783
      👍️0
      valleybenedetto valleybenedetto 4 months ago
      Smart this is the demand zone. Kick it into supply zone. 👍
      👍️0
      longrichard longrichard 4 months ago
      LOL

      Buy signal. Reloading.
      👍️0
      valleybenedetto valleybenedetto 4 months ago
      The chances of that are pretty strong unfortunately.
      👍️0
      maq1214 maq1214 4 months ago
      rest assured it sadly is
      👍️0
      JUST 10-11-12 JUST 10-11-12 4 months ago
      hope not a r/s
      👍️0
      valleybenedetto valleybenedetto 4 months ago
      They got themselves out now they will drop a research report and company needs to bring tangible news.
      👍️0
      DavidLeeRoth DavidLeeRoth 4 months ago
      I figured it would have tanked if someone was selling that many shares. Seems like something different is happening.🤷‍♂️
      👍️0
      valleybenedetto valleybenedetto 4 months ago
      The funder just pumped himself out of stock. Plain and simple.
      👍️0
      DavidLeeRoth DavidLeeRoth 4 months ago
      It was.
      👍️0

      Your Recent History

      NASDAQ
      VIRI
      Virios Therapeutics
      Delayed Upgrade Clock